About MagGenome
MagGenome is a company based in Kochi (India) founded in 2014 by Sam Santhosh and Sreedhar Santhosh. MagGenome has raised $1.11 million across 4 funding rounds from investors including S Arumugam, Emerge Ventures and SCI Ventures. The company has 30 employees as of April 06, 2024. MagGenome offers products and services including XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit. MagGenome operates in a competitive market with competitors including ArcherDX, Biofidelity, Molecular Assemblies, Ribbon Biolabs and FabricNano, among others.
- Headquarter Kochi, India
- Employees 30 as on 06 Apr, 2024
- Founders Sam Santhosh, Sreedhar Santhosh
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Maggenome Technologies Private Limited
- Date of Incorporation 25 May, 2015
- Jurisdiction Ernakulam, Kerala, India
-
Annual Revenue
$212.82 K (USD)-91.41as on Mar 31, 2023
-
Net Profit
-$505.62 K (USD)-173.17as on Mar 31, 2023
-
EBITDA
-$454.18 K (USD)-162.09as on Mar 31, 2023
-
Total Equity Funding
$1.11 M (USD)
in 4 rounds
-
Latest Funding Round
$175.58 K (USD), Angel Round
Mar 16, 2020
-
Investors
Emerge Ventures
& 2 more
-
Employee Count
30
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MagGenome
MagGenome offers a comprehensive portfolio of products and services, including XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit.
Kit for high-yield DNA extraction from blood samples.
Kit for DNA extraction from saliva for testing.
Kit for DNA extraction from tissue samples.
Beads for removing impurities from PCR reactions.
Kit for collecting and transporting saliva DNA.
People of MagGenome
Unlock access to complete
Unlock access to complete
Funding Insights of MagGenome
MagGenome has successfully raised a total of $1.11M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $175.58 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MagGenome
MagGenome has secured backing from 3 investors, including angel and venture fund investors. Prominent investors backing the company include S Arumugam, Emerge Ventures and SCI Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech and life sciences focused VC firm investing primarily in India and the US
|
Locked | Locked | Locked | |
|
Investments in women-led US companies are made by SCI Ventures.
|
Locked | Locked | Locked | |
|
SA
S Arumugam |
-
|
Locked | Locked | Locked |
Investor details for MagGenome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MagGenome
Investment portfolio details for MagGenome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MagGenome
Detailed financials for MagGenome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Maggenome Comparisons
Peer comparison for MagGenome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MagGenome
MagGenome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Biofidelity, Molecular Assemblies, Ribbon Biolabs and FabricNano, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Enzymatic DNA synthesis products are provided for researchers.
|
|
| Locked | Locked | Locked |
Long DNA molecules are synthesized via a high-throughput technology platform.
|
|
| Locked | Locked | Locked |
DNA-based flow reactors are developed for biochemical production.
|
|
| Locked | Locked | Locked |
Provider of oligonucleotide-based reagents and kits
|
Detailed competitors of MagGenome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Maggenome
Complete news archive for MagGenome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MagGenome
MagGenome was founded in 2014 and raised its 1st funding round 2 years after it was founded.
MagGenome is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
MagGenome is a funded company, having raised a total of $1.11M across 4 funding rounds to date.
As of Apr 06, 2024, the latest employee count at MagGenome is 30.
Annual revenue of MagGenome is $212.82K as on Mar 31, 2023.
MagGenome was founded in 2014 in Kochi, India, within the biotechnology sector. Genomic DNA extraction kits are provided through nanoparticle synthesis technology. Operations include the production of kits such as XpressDNA Blood mini kit and XpressDNA TissueCell line mini kit, along with the affinity resin-based XpressAffinity kit. Emphasis is placed on future diagnostics and therapeutic applications involving nanoparticle technology.
MagGenome's top competitors include FabricNano, ArcherDX and Molecular Assemblies.
MagGenome offers XpressDNA Blood Kit, XpressDNA Saliva Kit, XpressDNA Tissue Kit, XpressPure Beads, and MagStable DNA Saliva Collection Kit.
MagGenome has 3 investors. Key investors include S Arumugam, Emerge Ventures, and SCI Ventures.
The valuation of MagGenome is $3.13M as of Mar 2020.